Sowell Financial Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-114
Closed -$34K 3039
2021
Q1
$34K Sell
114
-51
-31% -$16.3K ﹤0.01% 1826
2020
Q4
$53K Buy
165
+3
+2% +$830 ﹤0.01% 1374
2020
Q3
$45K Buy
162
+7
+5% +$2.02K ﹤0.01% 1260
2020
Q2
$37K Hold
155
﹤0.01% 1271
2020
Q1
$22K Buy
155
+50
+48% +$8.3K ﹤0.01% 1367
2019
Q4
$18K Buy
105
+15
+17% +$2.78K ﹤0.01% 1482
2019
Q3
$16K Buy
+90
New +$19.5K ﹤0.01% 1376

Other funds holding ABMD

Sowell Financial Services's ABMD Position: Q2 2021 in Review

Sowell Financial Services sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 114 shares — an estimated $34K sold.

Sowell Financial Services first reported a position in ABMD in Q3 2019 and held it in 7 quarters. The position peaked at $53K in Q4 2020. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Sowell Financial Services reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 114 Abiomed Inc shares in Q2 2021, an estimated $34K.
  • Sowell Financial Services first reported a position in Abiomed Inc in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Abiomed Inc position peaked at $53K in Q4 2020.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.